| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |